BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 163681)

  • 1. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
    Boylan ES; Wittliff JL
    Cancer Res; 1975 Mar; 35(3):506-11. PubMed ID: 163681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM; Hilf R
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS; Sasaki GH; Leung JS
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, subcellular localization, and estrogen regulation of peroxidase in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    DeSombre ER; Anderson WA; Kang YH
    Cancer Res; 1975 Jan; 35(1):172-9. PubMed ID: 1109786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
    Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
    J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Gibson SL; Hilf R
    Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Garcia M; Rochefort H
    Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific estrogen receptor and its relation to response to oophorectomy in rat mammary cancer induced by 7,12-dimethylbenz[a]anthracene.
    Nomura Y; Abe Y; Inokuchi K
    Gan; 1974 Dec; 65(6):523-8. PubMed ID: 4377255
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
    Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
    Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Johnson ML; Levy J; Rosen JM
    Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific estrogen binding in vivo in the R3230AC mammary adenocarcinoma of the rat.
    Boylan ES; Wittliff JL
    Cancer Res; 1973 Nov; 33(11):2903-8. PubMed ID: 4355983
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Teller MN; Kaufman RJ; Bowie M; Stock CC
    Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
    Costlow ME; Buschow RA; McGuire WL
    Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-dependent in vitro stimulation of RNA synthesis in hormone-dependent mammary tumors of the rat.
    Arbogast LY; DeSombre ER
    J Natl Cancer Inst; 1975 Feb; 54(2):483-5. PubMed ID: 163335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.